drugset / Trial / NCT04235569

Warfarin Initiation in Mechanical Mitral Valve Replacement Patients

NCT04235569

Phase 4 Completed 50 enrolled Sarah Sabry Hashem
RandomizedParallel-groupSingle-blindTreatment

Summary

A prospective, comparative study evaluating warfarin initiation in a dose of 3mg versus 5mg in mechanical mitral valve prostheses patients who received anticoagulation with warfarin with the use of enoxaparen as a bridging agent .Fifty patients were included and compared in terms of the primary outcome time to reach therapeutic INR range.Other outcomes includes proportion of patients who achieved the target INR of 2.0-3.0 between day 3 and day 5, total dose of enoxaparin required for bridging, safety related to both doses of anticoagulants used

Timeline

Start
2018-03-01
Primary completion
2019-01-01
Completion
2019-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Enoxaparin sodium Other / unclassified 1 mg/kg
Subject Warfarin Small molecule 3 mg
Subject Warfarin Small molecule 5 mg

Indications